Common triglyceride-lowering variants at LPL and ANGPTL4 p.E40K in the lipoprotein lipase pathway are associated with reduced triglyceride concentrations, CHD odds, and T2D risk40,43,44. This evidence concerns the gene ANGPTL4 and coronary artery disorder.